Creative Planning’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$549K Sell
57,264
-2,673
-4% -$25.6K ﹤0.01% 2382
2025
Q1
$376K Buy
59,937
+36,694
+158% +$230K ﹤0.01% 2553
2024
Q4
$189K Sell
23,243
-10,641
-31% -$86.4K ﹤0.01% 2979
2024
Q3
$613K Buy
33,884
+6,933
+26% +$125K ﹤0.01% 1928
2024
Q2
$278K Sell
26,951
-5,151
-16% -$53.1K ﹤0.01% 2407
2024
Q1
$341K Buy
32,102
+10,750
+50% +$114K ﹤0.01% 2138
2023
Q4
$195K Buy
21,352
+877
+4% +$8.01K ﹤0.01% 2438
2023
Q3
$212K Hold
20,475
﹤0.01% 2188
2023
Q2
$293K Buy
20,475
+475
+2% +$6.8K ﹤0.01% 1919
2023
Q1
$143K Buy
+20,000
New +$143K ﹤0.01% 2186